Hepatic veno-occlusive disease (VOD) is a severe complication of hematopoietic stem cell transplantation (SCT). When monitored with hand-held color Doppler ultrasonography during day À7 to þ 35 around SCT, reversed blood flow in the segmental branches of the portal vein was detected in nine of 56 patients who had undergone SCT. Three of nine patients had clinical evidence of VOD, but six patients did not fulfill the criteria for diagnosis of VOD initially. Two patients progressed to clinical VOD at a later date and the reversed portal flow disappeared with or without treatment for VOD in the other four patients. Monitoring for reversed portal flow with color Doppler ultrasonography may be a useful tool for the early diagnosis of VOD, and may improve prognosis by allowing early initiation of treatment. In the early period following stem cell transplantation (SCT), hepatic veno-occlusive disease (VOD) is a severe complication; occurring in 10-50% of patients. [1] [2] [3] [4] The pathological background of VOD is a narrowing or obliteration of terminal hepatic venules in zone 3 of the hepatic acinus due to the deposition of fibrin, edema, and fibrosis of the vessel wall. 5, 6 Subsequently, it leads to hepatic necrosis, portal hypertension, hepatic failure, and finally multisystem organ failure. and Jones. 8 However, these criteria are based on clinical findings, such as weight gain, ascites, jaundice, and liver enlargement with tenderness. 7, 8 Although the use of a clinical diagnostic criteria accounts for severe established VOD, it cannot detect the early phase of VOD. As the mortality rate appears to correlate with severity of symptoms, an early diagnosis of VOD is important to allow for therapeutic intervention before the onset of clinical VOD with serious organ failure.
The pressure in the portal venous system increases in VOD and the flow velocity is reduced. Therefore, it is a prerequisite for the diagnosis of VOD that the portal venous flow is attenuated or reversed in the affected segments of the liver. It has been reported that color Doppler ultrasonography (US), which can be used to visualize the blood flow of hepatic vessels, is applicable to the diagnosis and monitoring of the therapeutic course of VOD because it is a noninvasive and convenient technique. 9 With the recent progress of noninvasive US techniques, an abnormally reversed flow in the segmental branches and/or main trunk of the portal vein can be easily and sensitively demonstrated by small and hand-held US equipment at the bedside. 10 
Patients and methods
We examined the presence of reversed blood flow in all segmental branches, main lobar branches and main trunk of the portal vein using hand-held color Doppler ultrasonography (SonoSite Inc, WA, USA) in 56 patients who had undergone hematopoietic SCT for hematological malignancies as a screening tool for hepatic VOD. The photo images of US were collected at breathholding in inspiration phase at supine position. US was performed every 7days around SCT (day À7 to þ 35) in Hamanomachi Hospital and Kurume University Hospital (Fukuoka, Japan) during the period of June 2002-July 2003. The age range was 9-72 years old. In all, 52 patients received allogeneic-SCT (19 related peripheral blood SCT (PBSCT), 26 unrelated bone marrow transplantation (BMT), five related BMT, two unrelated cord blood SCT, and four patients received autologous-PBSCT. In the allo-SCT, 32 patients received from HLA matched donors and 20 from HLA mismatched donors. The underlying diseases were AML (23 patients), AMixL (one patient), ALL (six patients), MDS (seven patients), CML (five patients), MM (two patients), NHL (eight patients), and ATLL (four patients). In all, 20 patients had a standard risk for the underlying disease (CR1 and CR2 for acute leukemia, chronic phase of CML, CR for MM and NHL) and the other 36 patients were defined as being in the high-risk group.
The diagnosis of VOD was performed according to McDonald's criteria. 7 All patients received a prophylactic administration of ursodeoxycholic acid (300 mg/day p.o.) for hepatic VOD. 11 Hepatic VOD was treated with the administration of prostaglandin E2, antithrombin concentrate and/or low molecular weight heparin.
Results
Reversed flow in the portal branches in liver segments 4 (P4) and/or 5 (P5) and main trunk of the portal vein was detected in nine of 56 patients (16.1%) using hand-held color Doppler US. The characteristics of these patients are shown in Table 1 . Although three of nine patients with regurgitation had already fulfilled the clinical McDonald criteria for VOD (Cases 1, 8, and 9) , the other six patients did not fulfill the diagnostic criteria when the reversed flow was first detected. In two of these six patients (Case 2 and 4), reversed blood flow disappeared following pre-emptive anticoagulant therapy (Figure 1a) . In Case 4, thrombotic microangiopathy occurred and the patient died of cerebral hemorrhage on day þ 83. In Cases 3 and 7, the reversed portal flow spontaneously normalized without any specific therapy (Figure 1b) . In Cases 5 and 6, typical VOD developed at a later date ( Figure 1c) ; one died of sepsis on day þ 43 and the other survived after receiving therapy for VOD. Two of three patients (Case 8 and 9) who had already fulfilled the clinical criteria for hepatic VOD at the time of the first detection of reversed flow recovered following anticoagulant therapy (Figure 1d ). Case 1, who showed reversed blood flow in the main trunk of the portal vein, developed multiorgan failure and he died rapidly (Figure 1e) .
Clinical evidence of hepatic VOD was seen in three additional patients (Table 2 ) in whom suitable USG study was not technically possible because of severe conditions. All three patients died of severe multisystem organ failure by day 31, despite aggressive treatment for VOD.
Discussion
Our data show that monitoring with color Doppler US after SCT makes it possible to detect VOD early in some patients on the basis of reversed blood flow in segmental branches of the portal vein. 
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Conventional US or magnetic resonance (MR) imaging has been reported to be useful for the diagnosis and monitoring of VOD. 12, 13 However, MR imaging is not convenient during the hematologic nadir. Alterations in hemostatic parameters such as plasminogen activator inhibitor type-1 (PAI-1), protein C, factor VII, antithrombin, von Willebrand Factor cleaving protease seen in VOD are not specific. [14] [15] [16] [17] In previous studies using duplex sonography, the hepatic artery resistive index (RI) value and amplitude of pulsatility in hepatic veins were reported to be significantly helpful for diagnosis of VOD. 18, 19 However, in a later study, these findings resulted in being of no value in the diagnosis of VOD. 20 The progression of color Doppler ultrasonographic vascular imaging techniques has made it possible to detect reversed portal flow with high sensitivity and reproducibility. In addition, hand-held equipment makes it easy and safe to handle the patient at the bedside in a bioclean room.
There have been the reports describing that the scoring of the portal flow rate with Doppler US findings correlated with the severity of hepatic VOD in young patients, 21 and reversed flow of the segmental portal vein was an early sign of hepatic VOD in infants. 22 Our results are in accordance with these findings.
Since no optimal treatment for VOD has as yet been established and delay in diagnosis increases mortality, pre-emptive treatment for VOD should be an important strategy. 23 It should be noted that the reversed flow regressed spontaneously in two patients suggesting that the finding may not be specific and the clinical condition of the patient should be considered in initiating pre-emptive therapy for VOD. [24] [25] [26] [27] [28] The early phase of rapidly progressive VOD in serious cases could not be detected by monitoring every 7 days. More frequent monitoring may be necessary in such patients. Furthermore, an important point about color Doppler US is the verification limit, especially in extremely obese patients or those who are very unwell.
In conclusion, reversed portal flow detected using handheld color Doppler equipment may permit early diagnosis of hepatic VOD. 
